FDA Investigator Nibin Varghese, MS

Nibin Varghese, MS has conducted inspections on 27 sites in 7 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
27
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100008340
Countries of Inspections:
Switzerland, Italy, United States of America, Philippines, Norway, France, Vietnam
FDA Investigators that have inspected at least one site in common with Nibin Varghese, MS:
Aditi S Thakur, Alan M Barker, Alicia M Mozzachio, Amanda S Zorn, Anders W Evenson, Andrew J Barrowcliff, Andrew J Lang, Annemarie Bodnar, Arsen Karapetyan, Brian D Nicholson, Bruce H Mccullough, Bryan L Mcguckin, Carrie Ann Plucinski, Caryn M Mcnab, Cassandra L Abellard, Chad E Schmear, Chad W Rice, Christina A Miller, Christopher D Leach, Constance L Richard, Constantin Y Philopoulos, Daniel J Brown, Darla J Christopher, David Perkins, Debra I Love, Denarvis C Mendenhall, Denise M Digiulio, Diane L Raccasi, Donna Mwilliams Hill, PhD, Enrico Joset Mangahis, Francis A Guidry, Gabriel Bermudez Picart, Greg Brinsley, Gregory R Brinsley, Howard Sklamberg, Jacob W Reynolds, James I Giefer, James W Plucinski, Jamie R Thompson, Janae D Price, Janet L Bowen, Janis R Armedoriz, Jason F Chancey, Jeffry A Bernhardt, Jennifer J Stone, Joanne E King, Joel D Hustedt, John M Seale, Joseph A Morkunas, Joseph A Piechocki, Justin A Boyd, Karen Emasley Joseph, Karen M Kondas, Kathleen R Jones, PhD, Kathleen S Tormey, Kevin D Kallander, Lauren N Howard, Lauren N Smith, Laurimer Kuilan Torres, Lequita M Mayhew, Linda F Murphy, Lindsey M Schwierjohann, Lindsey S Fleischman, Lisa C Lewis, Lisa Hornback, Lisa R Hilliar, Lori B Wikstrom, Lucas B Leake, Maksim A Levenchuk, Marcellinus D Dordunoo, Marcia A Worley, Marcus F Yambot, Maria Gutierrez Hoffman, PhD, Marie B Buen Bigornia, Mark G Peterson, Mary E Storch, Merry Christie, PhD, Michael A Charles, Michael L Casner, Michael R Goga, Michael Y Philopoulos, Michele L Glendenning, Muna Algharibeh, Nicholas F Lyons, Nicholas J Presto, Nicholas L Paulin, Nicholas P Diorio, Nicholas Z Lu, Nicole S Williams, Norman K Starks, Norman L Brown, Patricia A Mcilroy, Paul L Bellamy, Phung Thien Nguyen, Rafael Padilla, Ramesh Potla, PhD, Rebecca E Dombrowski, Richard G Fochesato, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert D Tollefsen, Rong Wang, PhD, Roshni J Patel, Ross J Grigsby, Russell K Riley, Samantha J Bradley, Sandra A Boyd, Sandra A Hughes, Sarah E Rhoades, Satheesh Thomas, Scott A Golladay, Shafiq S Ahadi, Stephen C Mahoney, Stephen D Eich, Steven Fong, MS, PhD, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Temar Q Williams, That Q Dang, Thuy T Nguyen, LCDR, Todd M Stankewicz, Tracy Denison, PhD, Tyler M Peterson, Tyler Peterson, Vaishali J Patel, Vioela J Caze, Vlada Matusovsky, Wendy G Tan, PhD, William D Sherman, William R Weissinger, Xiaoping Guan, Young Kim, Yuanyuan Li, Yvonne E Lozano

Nibin Varghese, MS's Documents

Publish Date Document Type Title
January, 2021 FDA 483 DENTAL TECHNOLOGIES, INC. - Form 483, 2021-01-20
November, 2022 FDA 483 Regis Technologies Inc. - Form 483, 2022-11-16
February, 2022 FDA 483 PQ Corporation - Form 483, 2022-02-22
November, 2021 FDA 483 FIRST PRIORITY INCORPORATED - Form 483, 2021-11-18
September, 2022 FDA 483 Woodbine Products Company - Form 483, 2022-09-01
February, 2023 FDA 483 Micro Measurement Laboratories, Inc. - Form 483, 2023-02-23
May, 2023 FDA 483 Brenntag Great Lakes, LLC - Form 483, 2023-05-05
October, 2022 EIR Particle Technology Labs - EIR, 2022-10-17
January, 2024 FDA 483 TJA Health LLC - Form 483, 2024-01-29
January, 2023 FDA 483 Nexus Pharmaceuticals, LLC - Form 483, 2023-01-20
January, 2022 FDA 483 Kashiv BioSciences, LLC - Form 483, 2022-01-14
March, 2024 FDA 483 Xttrium Laboratories, Inc. - Form 483, 2024-03-08
September, 2023 FDA 483 Isomedix Operations Inc - Form 483, 2023-09-18
May, 2021 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2021-05-20
November, 2023 FDA 483 Carma Laboratories, Inc. - Form 483, 2023-11-14
December, 2022 FDA 483 Xellia Pharmaceuticals USA LLC - Form 483, 2022-12-15
November, 2021 FDA 483 Response FIRST PRIORITY INCORPORATED - Form 483R, 2021-12-10
February, 2022 EIR PQ Corporation - EIR, 2022-02-22
June, 2022 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2022-06-30
November, 2021 EIR FIRST PRIORITY INCORPORATED - EIR, 2021-12-28
June, 2024 FDA 483 Kashiv BioSciences, LLC - Form 483, 2024-06-14
March, 2024 EIR Xttrium Laboratories, Inc. - EIR, 2024-03-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more